The expression of Lewisx and sialyl-Lewisx antigens was investigated immunohistochemically in 24 patients with intrahepatic cholangiocarcinoma. Seventeen cholangiocarcinomas of the hepatic hilum (hilar tumors) and 7 peripheral cholangiocellular carcinomas (peripheral tumors) were studied, as well as 9 normal livers obtained at autopsy.
Intrahepatic
cholangiocarcinoma is usually divided into hilar or peripheral tumors according to the location in the liver1,2). In a previous study, we investigated HLA -DR expression in intrahepatic cholangiocarcinoma and autopsied normal livers3) and we found that HLA-DR was expressed in the intrahepatic peribiliary glands but not by the bile duct epithelium. In additon, we showed that HLA-DR was more frequently expressed by intrahepatic cholangiocarcinomas of the hepatic hilum (hilar tumors) than by peripheral cholangiocellular carcinomas (peripheral tumors). In recent years, there have been reports on the expression of Lewisx antigen (Lex) and sialyl-Lewisx antigen connection with liver metastasis8,9 Tissues were fixed in 10% formal solution and embedded in paraffin. Several sections approximately 4mm thick were prepared from each block. After being deparaffinized, one section from each block was used for conventional histologic staining with hematoxylin and eosin.
Immunohistochemical studies were performed on the adjacent deparaffinized sections by the previously reported peroxidase-labeled streptavidin-biotin technique 12) using monoclonal antibodies for HLA-DR (1:50 dilu- HLA-DR staining was considered positive when it was detected in more than 10% of all tumor cells in a macroscopic field. For Lex and SLex staining, we applied the classification that we have used to assess the staining of pancreatic ductal epithelium for carbohydrate antigen 19-9 (CA 19-9) 13,14) with slight modifications. Four categories were defined according to the localization of Lex or SLex: (1) type N was negative staining, (2) type P(+) was membranous or cytoplasmic staining with preservation of the polar distribution of the antigens (with polarity), (3) type P(-) was membranous or cytoplasmic staining without preservation of the polar distri- bution of the antigens (without polarity), and (4) type S was stromal staining adjacent to the cancer cells. The cumulative survival rate was determined using the product-limited (Kaplan-Meier) method. The Cox-Mantel test was used to compare survival between two groups.
Results

Autopsied normal livers
The results of immunohistochemical staining for Lex and SLex are shown in Table 1 . Lex was recognized in the intrahepatic peribiliary glands of 6 livers, but was not expressed on the bile duct epithelium in any case ( Fig. 1 a, b). Although SLex was recognized in 4 normal livers, there was no difference in expression between the intrahepatic peribiliary glands and the bile duct epithelium ( Fig. 2-a, b ). Table 2 and 3. The hilar tumors showed the following staining patterns: type N in 7 cases, type P(+) in 3, type P (-) in 5, and type S in 2 . The peripheral tumors were stained as follows: type N in 1 case, type P(+) in 3, type P (-) in 3, and type S in O (Table  4 ). This analysis showed a trend towards a higher frequency of type N cases among the hilar tumors.
Examples of each staining pattern are shown in Fig. 3 .
When Lex staining was stratified according to the staining for HLA-DR, HLA-DR-negative tumors included more type N or P(+) cases than HLA-DR-positive tumors ( Table 5 ). The 5-year survival rate of patients with type P(-) and S hilar tumors (71%) was better than that of patients with type N and P(+) hilar tumors (50%), although the difference was not statistically significant (Fig. 4 ). 
SLex in cancer cells
There was no relationship of the distribution of SLex staining type with tumor type (hilar of peripheral), HLA-DR staining pattern, or histologic type. Moreover, patients with type P(-) and S hilar tumors had a similar 5-year survival rate (63%) to those with type N and P(+) tumors (56%). N: negative, type-P(+): membranous or cytoplasmic type with polarity, type-P(-): membranous or cytoplasmic type without polarity, type-S: stromal staining adjacent to the cancer cells.
Discussion
